Despite a notable downgrade in revenue growth forecasts and a rise in the future P/E ratio, the consensus analyst price target for Banco de Sabadell has increased slightly from €3.11 to €3.19.
What's in the News
- BBVA’s hostile takeover bid for Banco de Sabadell remains active after Spanish regulatory approval, but is subject to conditions requiring both banks to operate separately for at least three years.
- Sabadell is exploring the sale of its UK unit TSB, having received interest from Barclays and Santander; a deal decision is expected before a new strategic plan is unveiled.
- Sabadell plans a special shareholders meeting to approve an extraordinary dividend of €0.50 per share, contingent on completing the TSB sale.
- Sabadell has completed a share buyback program, repurchasing 264.6 million shares (4.94%) for €714.62 million.
- For 2025, Sabadell forecasts net income of €3.6 billion and mid-single-digit fee income growth.
Valuation Changes
Summary of Valuation Changes for Banco de Sabadell
- The Consensus Analyst Price Target has risen slightly from €3.11 to €3.19.
- The Consensus Revenue Growth forecasts for Banco de Sabadell has significantly fallen from 5.2% per annum to -3.7% per annum.
- The Future P/E for Banco de Sabadell has significantly risen from 11.33x to 13.19x.
Disclaimer
AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.